APC News
Commercialisation Impact Award
Commercialisation Impact Award
University College Cork (UCC), APC Microbiome Ireland and healthcare product developer PrecisionBiotics were named winners of the Commercialisation Impact Award. PrecisionBiotics – a UCC spin-out – was founded almost 20 years ago to develop probiotics for human and animal health.
This year, it was acquired by Danish biotech multinational Novozymes in a deal worth more than €80m, and KTI expects that the deal will strengthen collaborative links between the company and UCC.
When APC was established in 2003, with funding from SFI, PrecisionBiotics (then called Alimentary Health) was our founding industry partner. APC researchers have collaborated very closely with PrecisionBiotics for over two decades on the development of probiotics that impact on human health, such as Alflorex and Zenflore. We continue to collaborate closely with them today. We are delighted to have been part of this success story for Cork and Ireland and congratulate UCC Innovation and the team at PrecisionBiotics.
This year’s Knowledge Transfer Ireland (KTI) Impact Awards, held virtually due to Covid-19, saw more than 170 people from technology transfer offices, academia and industry tune in, along with investors and the wider business community. The awards aim to honour outstanding research that has been commercialised and has led to strong engagement between companies and research-performing organisations.
The awards were across three categories: commercialisation impact, industry engagement, and a new category for 2020 created in response to Covid-19 for efforts made by knowledge transfer offices to help tackle the disease.
Silicon Republic Article – https://www.siliconrepublic.com/innovation/kti-impact-awards-2020-nuig-intel
